Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • Telephone

      • +91 22-69790010 from 9 AM - 5:30 PM IST

      • Contact
      • Contact

        +91 22-69790010
        from 9 AM - 5:30 PM IST

    Close menu
  • News
  • Products
  • Contact
    • Request More Information
    • Journalists
    • 2 News in Focus
    • 5 Business & Money
    • 5 Science & Tech
    • 5 Lifestyle & Health
    • 1 Policy & Public Interest
    • 1 People & Culture
    • Request More Information
    • Journalists
    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • Request More Information
    • Journalists
    • General Inquiries
    • Worldwide Offices
    • Request More Information
    • Journalists
    Close submenu (News in Focus) News in Focus
    • Browse News Releases
    • Multimedia Gallery
    Close submenu (Business & Money) Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
    Close submenu (Science & Tech) Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
    Close submenu (Lifestyle & Health) Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
    Close submenu (Policy & Public Interest) Policy & Public Interest
    • Policy & Public Interest
    Close submenu (People & Culture) People & Culture
    • People & Culture

    Post Scheme of Arrangement, India Glycols reports its first financial results for Q2 FY27, Revenue of Rs. 358.18 Crore and EBITDA of Rs. 39.34 Crore


    News provided by

    India Glycols Limited

    17 Nov, 2026, 18:41 IST

    Share this article

    Share this article


    NOIDA, India, Nov. 17, 2026 /PRNewswire/ -- India Glycols Limited (NSE: INDIAGLYCO) (BSE: 500201) has announced its unaudited standalone financial results for the second quarter (Q2 FY27) and half year (H1 FY27) ended September 30, 2026. These results cover only the Company's continuing operations which retains Biobased Specialty Materials; Sustainable & Performance Chemicals, Gases. Its Spirits & Biofuel Undertaking and its Biopharma Undertaking have been demerged into IGL Spirits Limited and Ennature Bio Pharma Limited, and both are now separately listed. India Glycols' Revenue and EBITDA for the period are as follows:

    Results are not comparable in the context of demerger into three separate entities as detailed in the Note below*

    Key Financial Highlights: (Rs. in Crore)

    Particulars

    Q2 FY27

    Q2 FY26

    Q1 FY27

    Revenue from Operations

    358.18

    2,410.71

    354.64

    EBITDA

    39.34

    160.25

    40.21

    PAT

    11.24

    53.94

    12.35

    Quarterly EPS (in Rs.)

    1.68

    8.71

    1.84

    * The financial results of India Glycols Limited for Q2 FY27 reflect the continuing operations of the Company following the demerger of its Spirits & Biofuel Undertaking and Biopharma Undertaking into IGL Spirits Limited and Ennature Bio Pharma Limited, respectively

    Key Highlights for Q2 FY27:

    On a standalone basis, revenue from operations stood at Rs. 358.18 crore in Q2 FY27, compared to Rs. 2,410.71 crore in the corresponding quarter of the previous year.

    EBITDA for Q2 FY27 stood at Rs. 39.34 crore, compared to Rs. 160.25 crore in Q2 FY26.

    Profit After Tax (PAT) stood at Rs. 11.24 crore, as against Rs. 53.94 crore in the corresponding quarter of the previous year.

    The Q1 FY27 figures have been included in the table for reference. The Q2 FY26 comparative figures are also presented as reported in the previous year and should be read in the context of the demerger.

    Performance in H1 FY27

    Particulars

    H1 FY27

    H1 FY26

    Revenue from Operations

    712.82

    4,913.74

    EBITDA

    79.55

    309.51

    PAT

    23.59

    106.79

    Half-yearly EPS (in Rs.)

    3.52

    17.25

    * The financial results of India Glycols Limited for H1 FY27 reflect the continuing operations of the Company following the demerger of its Spirits & Biofuel Undertaking and Biopharma Undertaking into IGL Spirits Limited and Ennature Bio Pharma Limited, respectively.

    Key Highlights for H1 FY27:

    For H1 FY27, India Glycols Limited reported standalone revenue from operations of Rs. 712.82 crore, compared to Rs. 4,913.74 crore in H1 FY26.

    EBITDA for H1 FY27 stood at Rs. 79.55 crore, compared to Rs. 309.51 crore in the corresponding period of the previous year.

    The Profit After Tax (PAT) for H1 FY27 stood at Rs. 23.59 crore, as against Rs. 106.79 crore in H1 FY26.

    Commenting on the results, Mr. Rupark Sarswat, Chief Executive Officer, India Glycols Limited, said, "The implementation of the demerger marks an important step in the evolution of India Glycols, enabling a sharper focus on our core business of bio-based specialities and performance chemicals. We remain focused on strengthening our capabilities, enhancing operational efficiencies and building on our expertise in the bio-based chemicals space. Going forward, our efforts will be directed towards expanding our business opportunities and creating sustainable long-term value for our stakeholders."

    Note*: The Hon'ble National Company Law Tribunal (NCLT), Allahabad Bench, Prayagraj, vide its order dated July 17, 2026, approved the Scheme of Arrangement among India Glycols Limited, IGL Spirits Limited and Ennature Bio Pharma Limited for the demerger of the Spirits and Biofuel Undertaking into IGL Spirits Limited and the Biopharma Undertaking into Ennature Bio Pharma Limited. The Scheme became effective on September 1, 2026, with an appointed date of April 1, 2026. Accordingly, the Spirits and Biofuel Undertaking and the Biopharma Undertaking were demerged and vested in the respective resulting companies as going concerns with effect from the appointed date. The financial results of India Glycols Limited for Q2 FY27 and H1 FY27 do not include the financial performance of these two undertakings. The Q1 FY27 figures have been restated to give effect to the Scheme. The comparative figures for Q2 FY26 and H1 FY26 include the Spirits and Biofuel Undertaking and the Biopharma Undertaking, which have been demerged from the Company with effect from April 1, 2026. Accordingly, these comparative figures are not comparable with the corresponding current-period figures.

    Modal title

    Contact PR Newswire

    • +91 22-69790010

    Global Sites

    • APAC
    • APAC - Traditional Chinese
    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany

     

    • India
    • Indonesia
    • Israel
    • Italy
    • Mexico
    • Middle East
    • Middle East - Arabic
    • Netherlands
    • Norway
    • Poland

     

    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom
    • United States

    Do not sell or share my personal information:

    • Submit via [email protected] 
    • Call Privacy toll-free: 877-297-8921
    Global Sites
    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Israel
    • Italy
    • Mexico
    • Middle East
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom
    • United States
    +91 (0) 22 6169 6000
    from 9 AM - 5:30 PM IST
    • Terms of Use
    • Privacy Policy
    • GDPR
    • Information Security Policy
    • Site Map
    • Cookie Settings
    Copyright © 2026 Cision US Inc.